Back to today’s briefing

Story perspectives

Trump Administration Considers Price Controls on Medicaid Drugs

5/11/2025

27 3

Summary

Story summary

The Trump Administration is exploring the idea of implementing government price controls on Medicaid prescription drugs, inspired by European practices. Dr. Robert Campbell warns that this move could jeopardize the free market, limit patient access, and hinder innovation. He champions market-based reforms that promote competition and transparency for a healthier, more sustainable future for Americans.

1 of 1

Story summary

The Trump Administration is exploring the idea of implementing government price controls on Medicaid prescription drugs, inspired by European practices. Dr. Robert Campbell warns that this move could jeopardize the free market, limit patient access, and hinder innovation. He champions market-based reforms that promote competition and transparency for a healthier, more sustainable future for Americans.